Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Jones Judson Wade

2. Date of Event Requiring Statement (MM/DD/YYYY) 4/27/2017

3. Issuer Name and Ticker or Trading Symbol

Sabre Corp [SABR]

(Last) (First) (Middle)

3150 SABRE DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
Executive Vice President /

(Street)

SOUTHLAKE, TX 76092

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	11175 ⁽¹⁾	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options to Purchase Common Stock	⁽²⁾	1/15/2025	Common Stock	31109.0	$19.47	D
Options to Purchase Common Stock	⁽³⁾	3/13/2025	Common Stock	8176.0	$22.15	D
Options to Purchase Common Stock	⁽²⁾	3/15/2026	Common Stock	12660.0	$27.79	D
Options to Purchase Common Stock	⁽²⁾	3/15/2027	Common Stock	23220.0	$22.01	D

Explanation of Responses:
(1)	Includes a grant of 7,062 restricted stock unit awards on 1/15/15. The restricted stock unit award vested as to 25% of the shares of common stock subject to such award on each of 1/15/16 and 1/15/17 and will vest as to 25% of the shares on each of 1/15/18 and 1/15/19, subject to the Reporting Person's continued employment through each vesting date.
(2)	The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.
(3)	The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on 3/15/16 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Jones Judson Wade 3150 SABRE DRIVE SOUTHLAKE, TX 76092			Executive Vice President

Signatures
Steve W. Milton as attorney-in-fact for Judson Wade Jones		5/5/2017
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.